| HOME >> BIOLOGY >> TECHNOLOGY |
"The references to Fungitell(R) in the NCCN and IDSA's Guidelines are indicative of the increasing awareness of the potential benefit of early diagnosis of invasive fungal infections," said Dr. AJ Meuse. He further stated, "Early detection and treatment leads to better patient outcomes, shorter treatment regimens and may reduce the overall cost of treatment. Fungitell is an import aid to early diagnosis. The use of the Fungitell(R) assay has grown tremendously since its introduction in early 2005, and we are very optimistic that it will continue to be an integral part of the diagnosis and treatment of these critically ill patients. The EORTC-MSG definitions are looked to by the leading experts in mycotic diseases as key criteria for the standardization of diagnostic determinations of invasive fungal disease."
About Associates of Cape Cod, Inc.
Associates of Cape Cod, Inc., based in East Falmouth, MA, is a leader
in the field of bacterial endotoxin and beta-glucan detection and a major
supplier to the pharmaceutical, medical device and clinical diagnostic
industries. A wholly owned subsidiary of Seikagaku BioBusiness Corporation,
the Company pioneered the humane use of horseshoe crab blood extract,
Limulus Amebocyte Lysate (LAL), used in the testing of pharmaceuticals,
medical devices and biologics, for the presence of potentially toxic
endotoxins and glucans. Our products are marketed throughout the world
under the trade names Pyrotell(R), Glucatell(R), Pyrochrome(R) and
Chromo-LAL. The Company offers contract testing for endotoxin and
(1,3)-beta-D-glucan, and has a research biochemicals division, Northstar
BioProducts(TM), specializing in carbohydrate chemistry. For more
information about Associates of Cape Cod, Inc. and our prod
'/>"/>
| SOURCE Associates of Cape Cod, Inc. Copyright©2008 PR Newswire. All rights reserved |